New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
07:37 EDTDGXQuest Diagnostics pullback a buying opportunity, says Maxim
Maxim recommends using yesterday's pullback in shares of Quest Diagnostics as a buying opportunity. The firm views the company's 2014 outlook as conservative and reiterates a Buy rating on the stock.
News For DGX From The Last 14 Days
Check below for free stories on DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:08 EDTDGXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use